FIELD: chemistry.
SUBSTANCE: invention relates to substituted fluorene compounds and specifically to a compound of formula where R1 denotes a NH2-group or a Br atom; R2 denotes hydrogen or halogen; R3 is selected from the following group: oxygen, aminoalkyl group =N-alkyl, where alkyl C1-C12 (having normal or branched structure), aminoaryl group=N-aryl, where aryl: phenyl, naphthyl, aminoheteroaryl group=N-heteroaryl, where heteroaryl: pyridine, quinoline, phenylamine. The invention also relates to a method of slowing down proliferation of tumour cells, involving addition of an acceptable amount of an active compound of formula (1) into the medium, and to a method of inducing differentiation in mouse melanoma cells B16-F10.
EFFECT: novel compounds which can be active agents which inhibit tumour proliferation and activate differentiation in mouse melanoma cells B16-F10 are obtained and described.
11 cl, 8 tbl, 11 dwg
Title | Year | Author | Number |
---|---|---|---|
XANTHINE DERIVATIVES, HAVING ANTIPROLIFERATIVE ACTIVITY, CELL DIFFERENTIATION MODULATORS, METHOD OF SLOWING DOWN TUMOUR CELL PROLIFERATION, METHOD OF INDUCING DIFFERENTIATION IN CELLS | 2008 |
|
RU2424241C2 |
HETEROCYCLIC COMPOUNDS, HAVING ANTIPROLIFERATIVE ACTIVITY AND METHOD OF SLOWING DOWN TUMOUR CELL PROLIFERATION | 2008 |
|
RU2429232C2 |
THERAPEUTIC QUINONES | 2005 |
|
RU2411229C2 |
USE OF CYTOTOXIC AGENTS BASED ON SUBSTITUTED POTASSIUM 1-AMINO-1,6-DIOXO-2-CYANO-1-ETHOXY-6-R1-4-[((3-ETHOXYCARBONYL)-4,5,6,7-TETRAHYDROBENZO[b]THIOPHEN-2-yl)AMINO]HEXA-2,4-DIEN-3-OLATES IN TREATMENT OF LUNG MELANOMA | 2023 |
|
RU2808533C1 |
APPLICATION OF TRIINDOLYL METHANE DERIVATIVES AS ANTICANCER DRUGS | 2010 |
|
RU2454232C2 |
ANTITUMOUR AGENT BASED ON BIODEGRADABLE NANOPARTICLES CARRYING A RECOMBINANT HUMAN TUMOR NECROSIS FACTOR ALPHA | 2018 |
|
RU2691938C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING AGONIST OR ANTAGONIST OF ADENOSINE RECEPTOR | 2000 |
|
RU2239455C2 |
USE OF CYTOTOXIC AGENTS BASED ON SUBSTITUTED (E)-8-(2-OXO-2-R-ETHYLIDENE)-2-R1-3-R2-6-R3-PYRROLO[1,2-a]THIENO[3,2-e]PYRIMIDINE-4,7(5H,8H)-DIONES IN THE TREATMENT OF LUNG MELANOMA | 2023 |
|
RU2808534C1 |
INDUCING CELL DEATH BY INHIBITION OF ADAPTIVE HEAT SHOCK RESPONSE | 2009 |
|
RU2474612C2 |
METHOD OF MODIFICATION OF PERIPHERAL BLOOD MONOCYTES TO INCREASE THEIR PARACRINE ACTIVITY DURING AUTOLOGOUS TRANSPLANTATION | 2012 |
|
RU2497947C1 |
Authors
Dates
2011-01-20—Published
2008-12-19—Filed